Insider Cluster (3 insiders) ·Filed May 7, 2026

LMAT

LEMAITRE VASCULAR INC
BEARISH
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $3.0M total
Actionable Insight ▼ Bearish

Insider selling after a strong earnings beat is often routine, but the magnitude of CEO sales ($5M in two days) warrants monitoring for follow-on filings. If selling continues, it may signal limited near-term upside despite solid fundamentals.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
LMAT ▼ -3.98% at T+60d
SHORT call ✓ call won +3.98% · α vs SPY +7.82% · entry $107.91 → $103.61
Entry anchored
May 6, 03:59 PM ET
via exchange tick
T+1d
+0.03%
call -0.03% · α +0.80%
$107.94
settled 5mo ago
T+5d
-9.03%
call +9.03% · α +10.53%
$98.17
settled 5mo ago
T+20d
-15.08%
call +15.08% · α +18.21%
$91.64
settled 4mo ago
T+60d
-3.98%
call +3.98% · α +7.82%
$103.61
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Three LeMaitre Vascular insiders, including CEO George LeMaitre, sold a total of $3.0M in open-market shares within a week of a strong Q1 earnings beat and raised guidance. CEO sales alone totaled $5.0M over two days, representing routine profit-taking after the stock's recent run-up.

Key Financial Metrics

Direction
selling
Total Value
$3.0M
Insiders
3

Key Facts

  • CEO George LeMaitre sold $2.0M on May 7 and $3.0M on May 8 at ~$107-109/share.
  • Directors Lawrence Jasinski and Bridget Ross sold $434K and $560K respectively.
  • Total open-market sales of $3.0M represent ~0.12% of LMAT's $2.5B market cap.
  • Sales occurred 6 days after LMAT reported Q1 2026 EPS of $0.68 (+42% YoY) and raised full-year guidance.

Financial Impact

$3.0M in open-market insider sales, modest relative to $2.5B market cap

insider ownershipfloat

Risk Factors

  • Further insider selling could pressure the stock.
  • Stock may be fully valued after a strong run; multiple contraction risk.
  • Earnings beat already priced in; guidance raise may be insufficient to sustain momentum.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LMAT-1778538198155
11 reports for LMAT
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+20▲ +17.70%Jul 14, 2026
Filters
Rows
Reports for LMAT — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$80.45 $82.34▲ +2.35%▲ +2.09%$78.96 (−1.85%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$99.79 $82.13▲ +17.70%▲ +20.04%$78.96 (+20.87%)
May 7, 2026
21w ago
Insider Cluster
BEARISH ★ 4/10
$107.91 $91.64▲ +15.08%▲ +18.21%$78.96 (+26.83%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.96 (−26.83%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.91 $91.64▼ −15.08%▼ −18.21%$78.96 (−26.83%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$110.22 $91.64▼ −16.86%▼ −19.64%$78.96 (−28.36%)
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.96 (−32.74%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$117.39 $101.64▼ −13.42%▼ −19.71%$78.96 (−32.74%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$108.09 $112.71▲ +4.27%▲ +3.75%$78.96 (−26.95%)
Feb 26, 2026
31w ago
Insider Cluster
BEARISH ★ 7/10
$113.43 $110.33▲ +2.73%▼ −3.67%$78.96 (+30.39%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 11, 2026